The original patent for insulin was given away by it's discoverers because they wanted everyone to be able to have access to inexpensive insulin. That hasn't stopped pharma companies from coming up with patents around formulations, manufacturing methods, delivery methods, etc. and making tons of money off of insulin.
Sibling comments have pointed out the real reasons it's not commonly used despite the promise. I just wanted to point out not being able to patent something is almost never a barrier for pharmaceutical companies if they think they can come up with a profitable therapeutic.
[1] https://patents.google.com/patent/US10357522B2/en?q=phage+th...